Noninvasive Assessment of Intravascular Volume Status for Postoperative Patients

NCT ID: NCT03766451

Last Updated: 2018-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-10

Study Completion Date

2019-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ultrasound measurements of the inferior vena cava (IVC) have been proposed as a noninvasive tool to help guide fluid management. Well-established correlations exist between respiratory cycle-induced changes in IVC diameter and C entral Venous Pressure (CVP) . Beyond providing an estimate of CVP, the caval index, or percentage collapsibility of the IVC , has been proposed as a predictor of preload reserve. This noninvasive rapid measurement of CVP is especially important in critical care settings. It can help in differentiating hypovolemic, septic and cardiogenic shock. Changes in volume status will be depicted by change in the diameter of the IVC .

However, the validity and reliability of sonographic assessment of the inferior vena cava have been matters of controversy, and its applicability has been shown to be limited by technical difficulties. Recent study has shown a significant relationship between the internal jugular vein/common carotid artery (IJV/CCA) cross-sectional area ratio and CVP in pediatric burn patients .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Type and Site of The study:

This study will be be done at Beni-Suef university hospital ,Surgical Intensive Care Unit (SICU) after approval of the local ethics and research committee and anesthesia department of Beni- Suef University.

DATE AND PERIOD OF THE STUDY:

The study will be done between NOV. 2018 and Nov. 2019

Patients will be included:

Patients scheduled for elective or emergency major surgeries (e.g., abdominal exploration, cancer bladder, cancer rectum, cancer stomach and aorto-femoral bypass grafting) who require post-operative SICU admission for close monitoring and assessment of volume status will be considered for enrollment.

Thirty five patients will be enrolled in the study; the patients will be admitted to the post-surgical intensive care unit for post-operative close observation and monitoring for at least 24 h. Upon admission, baseline laboratory investigation, chest x-ray, Arterial Blood Gases (ABG) and vital signs (hear rate, mean arterial blood pressure, arterial oxygen saturation and temperature) will be all measured.

Patients will get nurse-controlled analgesia using morphine boluses of 1-2 mg intravenously, followed by a continuous infusion of 1 or 2 mg/h according to the protocol of the SICU team. CVP, sonographic measurement of (IJV/CCA) cross sectional area ratio and IVC diameter will be measured after admitting the patient to SICU as a baseline reading, second measurements will be after achieving CVP between (8-12 cmH2O).

Data to be collected and measured

Demographic data will be obtained from patient's notes and charts including

1- Age, sex, body mass index, ASA physical status and type of surgery.

Cardiorespiratory variables of the Patients include:

* CVP (CMH2O),
* Heart rate (beats/min),
* MAP( mmHg),
* Oxygen saturation (spo2 %),
* Urine output (ml/h),

IVC measurements include:

* IVC Maximum Diameter (cm).
* IVC Minimum Diameter (cm).

Internal jugular vein and common carotid artery measurements include:

* CCA Surface
* IJV surface at inspiration
* IJV surface at expiration
* IJV/CCA RATIO at inspiration
* IJV/CCA RATIO at expiration

Data will be measured after admitting the patient to SICU as a baseline reading, second measurements will be after achieving CVP between (8-12 cmH2O).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intravascular Volume

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. ASA physical status I and II
2. Patients who are able to breathe spontaneously and lay supine post-operative.
3. Patients who had CVP catheter (subclavian or internal jugular vein)

Exclusion Criteria

* 1- Chronic obstructive or restrictive pulmonary disease. 2-Significant cardiac disease 3-Significant hepatic disease 4-Renal impairment ( creatinine \>2 mg/dl). 5- BMI ˃ 30 kg/m2 6- Pneumothorax or mediastinal masses. 7- mechanical ventilation or coming with tracheostomy. 8- defect at the site of sonography. 9- Pregnancy. 10- Instability of vital signs 11- Unwillingness to participate 12- sepsis or septic shock. 13- neurosurgical interventions
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beni-Suef University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hebatullah Negm Eldeen Abd El Azeem

Assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hebatullah Negm eldeen, A.L.

Role: PRINCIPAL_INVESTIGATOR

Beni-Suef University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hebatullah Negm Eldeen

Banī Suwayf, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

samaa rashwan, A.P

Role: primary

01208929154

Ahmed Goda, MD

Role: backup

01111861863

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Hebatullah Negm Eldeen

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.